{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T22:58:56Z","timestamp":1790895536238,"version":"4.1.0"},"reference-count":20,"publisher":"American Medical Association (AMA)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2020.17645","type":"journal-article","created":{"date-parts":[[2020,9,30]],"date-time":"2020-09-30T21:03:31Z","timestamp":1601499811000},"page":"e2017645","source":"Crossref","is-referenced-by-count":24,"title":["Comparative Effectiveness of Generic vs Brand-Name Levothyroxine in Achieving Normal Thyrotropin Levels"],"prefix":"10.1001","volume":"3","author":[{"given":"Juan P.","family":"Brito","sequence":"first","affiliation":[{"name":"Knowledge and Evaluation Research Unit, Division of Endocrinology, Diabetes, Metabolism and Nutrition, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph S.","family":"Ross","sequence":"additional","affiliation":[{"name":"Section of General Internal Medicine and the National Clinician Scholars Program, Yale School of Medicine, New Haven, Connecticut"},{"name":"Department of Health Policy and Management, Yale School of Public Health, New Haven, Connecticut"},{"name":"Center for Outcomes Research and Evaluation, Yale\u2013New Haven Hospital, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsey","family":"Sangaralingham","sequence":"additional","affiliation":[{"name":"Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah K.","family":"Dutcher","sequence":"additional","affiliation":[{"name":"Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, Food and Drug Administration (FDA), Silver Spring, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Graham","sequence":"additional","affiliation":[{"name":"Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, Food and Drug Administration (FDA), Silver Spring, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong","family":"Wang","sequence":"additional","affiliation":[{"name":"Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, FDA, Silver Spring, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yute","family":"Wu","sequence":"additional","affiliation":[{"name":"Office of Biostatistics, Office of Translational Sciences, Center for Drug Evaluation and Research, FDA, Silver Spring, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxi","family":"Yao","sequence":"additional","affiliation":[{"name":"Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota"},{"name":"Division of Health Care Policy & Research, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert C.","family":"Smallridge","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Mayo Clinic, Jacksonville, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Bernet","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Mayo Clinic, Jacksonville, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilay D.","family":"Shah","sequence":"additional","affiliation":[{"name":"Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota"},{"name":"Division of Health Care Policy & Research, Mayo Clinic, Rochester, Minnesota"},{"name":"Optum Labs, Cambridge, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kasia J.","family":"Lipska","sequence":"additional","affiliation":[{"name":"Center for Outcomes Research and Evaluation, Yale\u2013New Haven Hospital, New Haven, Connecticut"},{"name":"Section of Endocrinology, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2020,9,30]]},"reference":[{"issue":"4","key":"zoi200634r1","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/S2213-8587(16)30276-5","article-title":"Levothyroxine overuse: time for an about face?","volume":"5","author":"Rodriguez-Gutierrez","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"17","key":"zoi200634r2","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1001\/jama.2015.13766","article-title":"Trends in prescription drug use among adults in the United States from 1999-2012.","volume":"314","author":"Kantor","year":"2015","journal-title":"JAMA"},{"issue":"11","key":"zoi200634r3","doi-asserted-by":"publisher","first-page":"785","DOI":"10.7326\/0003-4819-157-11-201212040-00538","article-title":"Interventions to improve adherence to self-administered medications for chronic diseases in the United States: a systematic review.","volume":"157","author":"Viswanathan","year":"2012","journal-title":"Ann Intern Med"},{"issue":"6","key":"zoi200634r5","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1210\/jc.2018-02197","article-title":"Generic and brand-name thyroid hormone drug use among commercially insured and Medicare beneficiaries, 2007 through 2016.","volume":"104","author":"Ross","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"zoi200634r6","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1210\/jc.2014-1046","article-title":"A 2013 survey of clinical practice patterns in the management of primary hypothyroidism.","volume":"99","author":"Burch","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"zoi200634r7","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1111\/j.1524-4733.2009.00600.x","article-title":"Good research practices for comparative effectiveness research: defining, reporting and interpreting nonrandomized studies of treatment effects using secondary data sources: the ISPOR Good Research Practices for Retrospective Database Analysis Task Force Report\u2014part I.","volume":"12","author":"Berger","year":"2009","journal-title":"Value Health"},{"issue":"7","key":"zoi200634r8","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1377\/hlthaff.2014.0038","article-title":"Optum Labs: building a novel node in the learning health care system.","volume":"33","author":"Wallace","year":"2014","journal-title":"Health Aff (Millwood)"},{"issue":"6","key":"zoi200634r9","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/0895-4356(92)90133-8","article-title":"Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases.","volume":"45","author":"Deyo","year":"1992","journal-title":"J Clin Epidemiol"},{"issue":"2","key":"zoi200634r11","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.003074","article-title":"Effect of adherence to oral anticoagulants on risk of stroke and major bleeding among patients with atrial fibrillation.","volume":"5","author":"Yao","year":"2016","journal-title":"J Am Heart Assoc"},{"issue":"12","key":"zoi200634r12","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1089\/thy.2014.0028","article-title":"Guidelines for the treatment of hypothyroidism: prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement.","volume":"24","author":"Jonklaas","year":"2014","journal-title":"Thyroid"},{"issue":"387","key":"zoi200634r14","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1080\/01621459.1984.10478078","article-title":"Reducing bias in observational studies using subclassification on the propensity score.","volume":"79","author":"Rosenbaum","year":"1984","journal-title":"J Am Stat Assoc"},{"issue":"427","key":"zoi200634r15","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1080\/01621459.1994.10476818","article-title":"Estimation of regression coefficients when some regressors are not always observed.","volume":"89","author":"Robins","year":"1994","journal-title":"J Am Stat Assoc"},{"issue":"4","key":"zoi200634r18","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1001\/archinte.160.4.526","article-title":"The Colorado thyroid disease prevalence study.","volume":"160","author":"Canaris","year":"2000","journal-title":"Arch Intern Med"},{"issue":"2","key":"zoi200634r19","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1210\/jc.2012-3125","article-title":"Generic and brand-name L-thyroxine are not bioequivalent for children with severe congenital hypothyroidism.","volume":"98","author":"Carswell","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"zoi200634r20","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.clinthera.2017.01.005","article-title":"Factors affecting gastrointestinal absorption of levothyroxine: a review.","volume":"39","author":"Skelin","year":"2017","journal-title":"Clin Ther"},{"key":"zoi200634r13","first-page":"348","volume-title":"Williams Textbook of Endocrinology","author":"Melmed","year":"2011","edition":"12th ed"},{"key":"zoi200634r4","unstructured":"Association for Accessible Medicines. Generic drug access savings in the United States: access in jeopardy. Published 2018. Accessed June 15, 2020. https:\/\/accessiblemeds.org\/sites\/default\/files\/2018_aam_generic_drug_access_and_savings_report.pdf"},{"key":"zoi200634r10","unstructured":"Nau? DP. Proportion of days covered (PDC) as a preferred method of measuring medication adherence. Pharmacy Quality Alliance; 2012. Accessed March 15, 2019. http:\/\/ep.yimg.com\/ty\/cdn\/epill\/pdcmpr.pdf"},{"key":"zoi200634r16","unstructured":"Endocrine Society. Bioequivalence of sodium levothyroxine: an Endocrine Society Position Statement. Published June 1, 2008. Accessed March 15, 2019. https:\/\/www.endocrine.org\/advocacy\/position-statements\/bioequivalence-of-sodium-levothyroxine?"},{"key":"zoi200634r17","unstructured":"US Food and Drug Administration. FDA acts to ensure thyroid drugs don\u2019t lose potency before expiration date. Published October 3, 2007. Accessed April 8, 2019. https:\/\/www.fda.gov\/Drugs\/DrugSafety\/PostmarketDrugSafetyInformationforPatientsandProviders\/ucm161259.htm"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2771041\/brito_2020_oi_200634_1600707295.34439.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,30]],"date-time":"2020-09-30T21:03:49Z","timestamp":1601499829000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2771041"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,30]]},"references-count":20,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.17645","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,30]]}}}